Elucidating the exact pharmacological system of action (MOA) of naturally developing compounds is often challenging. Despite the fact that Tarselli et al. (60) made the first de novo synthetic pathway to conolidine and showcased that this The natural way happening compound successfully suppresses responses to the two chemically induced and inflamma